Biden rule cleared hurdles to lifesaving HIV drug, but in Georgia barriers remain

Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has faced repeated challenges getting the lifesaving drug that can prevent new HIV infections.

MSD secures worldwide license for LaNova’s LM-299

The agreement is set to conclude in Q4 2024. Credit: Merck & Co. MSD has secured an exclusive worldwide license from LaNova Medicines for developing,

November 15, 2024

Trust in Doctors Crashed During the COVID Pandemic — And Remains Low

Trust in physicians and hospitals decreased sharply during the COVID-19 pandemic, and higher levels of trust were tied to greater odds of getting vaccinated for

August 1, 2024

Little-known startup, backed by Foresite and Samsara, swings $60M China I&I deal

A new, still-in-stealth biotech is paying eight figures to acquire the rights to an experimental I&I drug out of China. Vignette Bio — a company

September 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.